Aslan Stock Volatility

Aslan Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.2, which signifies that the company had -0.2% of return per unit of risk over the last 3 months. Macroaxis standpoint towards foreseeing the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Aslan Pharmaceuticals exposes twenty-one different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm Aslan Pharmaceuticals risk adjusted performance of (0.15), and Mean Deviation of 3.61 to double-check the risk estimate we provide.

Aslan Volatility 

 
Refresh
Aslan Pharmaceuticals Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Aslan daily returns, and it is calculated using variance and standard deviation. We also use Aslan's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Aslan Pharmaceuticals volatility.

Aslan Pharmaceuticals Stock Volatility Analysis

Volatility refers to the frequency at which Aslan Pharmaceuticals stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Aslan Pharmaceuticals' price changes. Investors will then calculate the volatility of Aslan Pharmaceuticals' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Aslan Pharmaceuticals' volatility:

Historical Volatility

This type of stock volatility measures Aslan Pharmaceuticals' fluctuations based on previous trends. It's commonly used to predict Aslan Pharmaceuticals' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for Aslan Pharmaceuticals' current market price. This means that the stock will return to its initially predicted market price.
Transformation
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.

Aslan Pharmaceuticals Projected Return Density Against Market

Given the investment horizon of 90 days Aslan Pharmaceuticals has a beta of 0.4442 . This suggests as returns on the market go up, Aslan Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Aslan Pharmaceuticals will be expected to be much smaller as well.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Aslan Pharmaceuticals or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Aslan Pharmaceuticals stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Aslan stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Aslan Pharmaceuticals is significantly underperforming DOW.
 Predicted Return Density 
      Returns 
Aslan Pharmaceuticals' volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how Aslan Pharmaceuticals stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives a Company's Stock Price Volatility?

Several factors can influence a company's stock volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

Aslan Pharmaceuticals Stock Risk Measures

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Aslan Pharmaceuticals or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Aslan Pharmaceuticals stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Aslan stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Given the investment horizon of 90 days the coefficient of variation of Aslan Pharmaceuticals is -499.04. The daily returns are distributed with a variance of 34.24 and standard deviation of 5.85. The mean deviation of Aslan Pharmaceuticals is currently at 3.61. For similar time horizon, the selected benchmark (DOW) has volatility of 0.79
α
Alpha over DOW
-1.15
β
Beta against DOW0.44
σ
Overall volatility
5.85
Ir
Information ratio -0.19

Aslan Pharmaceuticals Stock Return Volatility

Aslan Pharmaceuticals historical daily return volatility represents how much Aslan Pharmaceuticals stock's price daily returns swing around its mean daily price change - it is a statistical measure of its dispersion of returns. The company inherits 5.8515% risk (volatility on return distribution) over the 90 days horizon. By contrast, DOW inherits 0.8098% risk (volatility on return distribution) over the 90 days horizon.
 Performance (%) 
      Timeline 

Aslan Pharmaceuticals Investment Opportunity

Aslan Pharmaceuticals has a volatility of 5.85 and is 7.22 times more volatile than DOW. 50  of all equities and portfolios are less risky than Aslan Pharmaceuticals. Compared to the overall equity markets, volatility of historical daily returns of Aslan Pharmaceuticals is higher than 50 () of all global equities and portfolios over the last 90 days. Use Aslan Pharmaceuticals to protect your portfolios against small market fluctuations. The stock experiences a normal downward trend, but the immediate impact on correlations cannot be determined at the moment . Check odds of Aslan Pharmaceuticals to be traded at $0.0 in 90 days. . Let's try to break down what Aslan's beta means in this case. As returns on the market increase, Aslan Pharmaceuticals returns are expected to increase less than the market. However, during the bear market, the loss on holding Aslan Pharmaceuticals will be expected to be smaller as well.

Significant diversification

The correlation between Aslan Pharmaceuticals Ltd and DJI is Significant diversification for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Aslan Pharmaceuticals Ltd and DJI in the same portfolio assuming nothing else is changed.

Aslan Pharmaceuticals Additional Risk Indicators

The analysis of Aslan Pharmaceuticals' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Aslan Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some common measures of Aslan Pharmaceuticals stock risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Risk Adjusted Performance(0.15)
Market Risk Adjusted Performance(2.65)
Mean Deviation3.61
Coefficient Of Variation(499.04)
Standard Deviation5.85
Variance34.24
Information Ratio(0.19)
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stock investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Aslan Pharmaceuticals Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
Du Pont vs. Aslan Pharmaceuticals
Salesforce vs. Aslan Pharmaceuticals
Sentinelone Inc vs. Aslan Pharmaceuticals
Walker Dunlop vs. Aslan Pharmaceuticals
Vmware vs. Aslan Pharmaceuticals
Visa vs. Aslan Pharmaceuticals
Microsoft Corp vs. Aslan Pharmaceuticals
GM vs. Aslan Pharmaceuticals
Ford vs. Aslan Pharmaceuticals
Twitter vs. Aslan Pharmaceuticals
Meta Platforms vs. Aslan Pharmaceuticals
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Aslan Pharmaceuticals as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Aslan Pharmaceuticals' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Aslan Pharmaceuticals' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Aslan Pharmaceuticals.
Check out Trending Equities. Note that the Aslan Pharmaceuticals information on this page should be used as a complementary analysis to other Aslan Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Tools for Aslan Stock

When running Aslan Pharmaceuticals price analysis, check to measure Aslan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aslan Pharmaceuticals is operating at the current time. Most of Aslan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aslan Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Aslan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aslan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go